The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of gene expression determinants of radiosensitivity in bladder cancer (BC) cell lines.
 
Jasmine Pettiford
No Relationships to Disclose
 
Summya Rashid
No Relationships to Disclose
 
Aysegul Balyimez
No Relationships to Disclose
 
Tomas Radivoyevitch
No Relationships to Disclose
 
Vadim S. Koshkin
No Relationships to Disclose
 
Daniel J. Lindner
No Relationships to Disclose
 
Yvonne Parker
No Relationships to Disclose
 
Mark L. Day
No Relationships to Disclose
 
Kathleen C. Day
No Relationships to Disclose
 
Scott Tomlins
Leadership - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Consulting or Advisory Role - Abbvie; Almac Diagnostics; Astellas Medivation; Janssen; Sanofi; Strata Oncology
Research Funding - Astellas Medivation (Inst); GenomeDx (Inst)
Patents, Royalties, Other Intellectual Property - Hologic/Gen-Probe Inc.
Travel, Accommodations, Expenses - Strata Oncology
 
Nouri Neamati
No Relationships to Disclose
 
Brendan Veeneman
No Relationships to Disclose
 
Guadalupe Lorenzatti Hiles
No Relationships to Disclose
 
Philip Palmbos
No Relationships to Disclose
 
Byron Lee
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Dendreon; Driver, Inc; EMD Serono; Exelixis; Foundation Medicine; Genentech; Merck; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Omar Y. Mian
No Relationships to Disclose